Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  MEK-1/MEKK-1 inhibitor E6201
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 Mutation
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BSC-101-01, NCI-2015-00719, NCT02418000
Start Over